Publications

  1. Pittock SJ, Lennon VA, McKeon A, Mandrekar J, Weinshenker BG, Lucchinetti CF, O'Toole O, Wingerchuk DM. Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study. Lancet Neurol. 2013 Jun; 12(6):554-62. Epub 2013 Apr 26. 2319962
    View PubMed
  2. McKeon A, Lennon VA, LaChance DH, Klein CJ, Pittock SJ. Striational antibodies in a paraneoplastic context. Muscle Nerve. 2013 Apr; 47(4):585-7. Epub 2013 Mar 05. 2308706
    View PubMed
  3. O'Toole O, Lennon VA, Ahlskog JE, Matsumoto JY, Pittock SJ, Bower J, Fealey R, Lachance DH, McKeon A. Autoimmune chorea in adults. Neurology. 2013 Mar 19; 80(12):1133-44. Epub 2013 Feb 20. 2305455
    View PubMed
  4. Iorio R, Lucchinetti CF, Lennon VA, Farrugia G, Pasricha PJ, Weinshenker BG, Pittock SJ. Intractable nausea and vomiting from autoantibodies against a brain water channel. Clin Gastroenterol Hepatol. 2013 Mar; 11(3):240-5. Epub 2012 Dec 01. 2288194
    View PubMed
  5. Iorio R, Fryer JP, Hinson SR, Fallier-Becker P, Wolburg H, Pittock SJ, Lennon VA. Astrocytic autoantibody of neuromyelitis optica (NMO-IgG) binds to aquaporin-4 extracellular loops, monomers, tetramers and high order arrays. J Autoimmun. 2013 Feb; 40:21-7. Epub 2012 Aug 18. 2265320
    View PubMed
  6. Tutuncu M, Tang J, Zeid NA, Kale N, Crusan DJ, Atkinson EJ, Siva A, Pittock SJ, Pirko I, Keegan BM, Lucchinetti CF, Noseworthy JH, Rodriguez M, Weinshenker BG, Kantarci OH. Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis. Mult Scler. 2013 Feb; 19(2):188-98. Epub 2012 Jun 26. 2253885
    View PubMed
  7. Klein CJ, Lennon VA, Aston PA, McKeon A, O'Toole O, Quek A, Pittock SJ. Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping. JAMA Neurol. 2013 Feb; 70(2):229-34. 2310744
    View PubMed
  8. McKeon A, Martinez-Hernandez E, Lancaster E, Matsumoto JY, Harvey RJ, McEvoy KM, Pittock SJ, Lennon VA, Dalmau J. Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype. JAMA Neurol. 2013 Jan; 70(1):44-50. 2278838
    View PubMed
  9. Klaas JP, Ahlskog JE, Pittock SJ, Matsumoto JY, Aksamit AJ, Bartleson JD, Kumar R, McEvoy KF, McKeon A. Adult-onset opsoclonus-myoclonus syndrome. Arch Neurol. 2012 Dec; 69(12):1598-607. 2278825
    View PubMed
  10. Flanagan EP, Sandroni P, Pittock SJ, Inwards DJ, Jones LK Jr. Paraneoplastic lower motor neuronopathy associated with Hodgkin lymphoma. Muscle Nerve. 2012 Nov; 46(5):823-7. 2276795
    View PubMed
  11. Miles SL, Niles RM, Pittock S, Vile R, Davies J, Winters JL, Abu-Yaghi NE, Grothey A, Siddiqui M, Kaur J, Hartmann L, Kalli KR, Pease L, Kravitz D, Markovic S, Pulido JS. A factor found in the IgG fraction of serum of patients with paraneoplastic bilateral diffuse uveal melanocytic proliferation causes proliferation of cultured human melanocytes. Retina. 2012 Oct; 32(9):1959-66. 2257697
    View PubMed
  12. Apiwattanakul M, Asawavichienjinda T, Pulkes T, Tantirittisak T, Hemachudha T, Horta ES, Jenkins SM, Pittock SJ. Diagnostic utility of NMO/AQP4-IgG in evaluating CNS inflammatory disease in Thai patients. J Neurol Sci. 2012 Sep 15; 320(1-2):118-20. Epub 2012 Jul 24. 2267569
    View PubMed
  13. Klein CJ, Lennon VA, Aston PA, McKeon A, Pittock SJ. Chronic pain as a manifestation of potassium channel-complex autoimmunity. Neurology. 2012 Sep 11; 79(11):1136-44. Epub 2012 Aug 15. 2264413
    View PubMed
  14. Quek AM, McKeon A, Lennon VA, Mandrekar JN, Iorio R, Jiao Y, Costanzi C, Weinshenker BG, Wingerchuk DM, Lucchinetti CF, Shuster EA, Pittock SJ. Effects of age and sex on aquaporin-4 autoimmunity. Arch Neurol. 2012 Aug; 69(8):1039-43. 2238901
    View PubMed
  15. Tarula E, Ramkissoon S, Pittock S, Sheen VL. Progressive mental status changes and seizures with fluid attenuated inversion recovery (FLAIR) hyperintensity on brain MRI. J Clin Neurosci. 2012 Jun; 19(6):873, 924. 2248950
    View PubMed
  16. Eggers SD, Pittock SJ, Shepard NT, Habermann TM, Neff BA, Klebig RR. Positional periodic alternating vertical nystagmus with PCA-Tr antibodies in Hodgkin lymphoma. Neurology. 2012 May 29; 78(22):1800-2. Epub 2012 May 16. 2246672
    View PubMed
  17. Quek AM, Britton JW, McKeon A, So E, Lennon VA, Shin C, Klein C, Watson RE Jr, Kotsenas AL, Lagerlund TD, Cascino GD, Worrell GA, Wirrell EC, Nickels KC, Aksamit AJ, Noe KH, Pittock SJ. Autoimmune epilepsy: clinical characteristics and response to immunotherapy. Arch Neurol. 2012 May; 69(5):582-93. 2235248
    View PubMed
  18. Bunyan RF, Pittock SJ. Do not treat from CIS onset: evaluate disease course and prognosis first--yes. Mult Scler. 2012 Apr; 18(4):391-3. 2242322
    View PubMed
  19. Meeusen JW, Klein CJ, Pirko I, Haselkorn KE, Kryzer TJ, Pittock SJ, Lachance DH, Dyck PJ, Lennon VA. Potassium channel complex autoimmunity induced by inhaled brain tissue aerosol. Ann Neurol. 2012 Mar; 71(3):417-26. 2234933
    View PubMed
  20. Soldan MM, Pittock SJ, Weigand SD, Yawn BP, Rodriguez M. Statin therapy and multiple sclerosis disability in a population-based cohort. Mult Scler. 2012 Mar; 18(3):358-63. Epub 2011 Sep 09. 2229081
    View PubMed
  21. Waters PJ, McKeon A, Leite MI, Rajasekharan S, Lennon VA, Villalobos A, Palace J, Mandrekar JN, Vincent A, Bar-Or A, Pittock SJ. Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology. 2012 Feb 28; 78(9):665-71; discussion 669. Epub 2012 Feb 01. 2221389
    View PubMed
  22. McKeon A, Robinson MT, McEvoy KM, Matsumoto JY, Lennon VA, Ahlskog JE, Pittock SJ. Stiff-man syndrome and variants: clinical course, treatments, and outcomes. Arch Neurol. 2012 Feb; 69(2):230-8. 2224224
    View PubMed
  23. Storoni M, Pittock SJ, Weinshenker BG, Plant GT. Optic neuritis in an ethnically diverse population: higher risk of atypical cases in patients of African or African-Caribbean heritage. J Neurol Sci. 2012 Jan 15; 312(1-2):21-5. Epub 2011 Sep 14. 2216629
    View PubMed
  24. Apiwattanakul M, Asawavichienjinda T, Pulkes T, Tantirittisak T, Hemachudha T, Horta ES, Jenkins SM, Pittock SJ. Erratum: Diagnostic utility of NMO/AQP4-IgG in evaluating CNS inflammatory disease in Thai patients (Journal of the Neurological Sciences (2012) 320 (118-120)). J Neurol Sci. 2012; 323(1-2):273. 2284137
  25. Jaben EA, Pulido JS, Pittock S, Markovic S, Winters JL. The potential role of plasma exchange as a treatment for bilateral diffuse uveal melanocytic proliferation: a report of two cases. J Clin Apher. 2011 Dec; 26(6):356-61. Epub 2011 Sep 5. 2189405
    View PubMed
  26. Caplan JP, Binius T, Lennon VA, Pittock SJ, Rao MS. Pseudopseudoseizures: conditions that may mimic psychogenic non-epileptic seizures. Psychosomatics. 2011 Nov-Dec; 52(6):501-6. Epub 2011 Sep 22. 2211508
    View PubMed
  27. Iorio R, Lucchinetti CF, Lennon VA, Costanzi C, Hinson S, Weinshenker BG, Pittock SJ. Syndrome of inappropriate antidiuresis may herald or accompany neuromyelitis optica. Neurology. 2011 Oct 25; 77(17):1644-6. Epub 2011 Oct 12. 2199631
    View PubMed
  28. Klein CJ, Kimmel GW, Pittock SJ, Engelstad JE, Cunningham JM, Wu Y, Dyck PJ. Large kindred evaluation of mitofusin 2 novel mutation, extremes of neurologic presentations, and preserved nerve mitochondria. Arch Neurol. 2011 Oct; 68(10):1295-302. 2197942
    View PubMed
  29. McKeon A, Pittock SJ. Paraneoplastic encephalomyelopathies: pathology and mechanisms. Acta Neuropathol. 2011 Oct; 122(4):381-400. Epub 2011 Sep 22. 2193917
    View PubMed
  30. McKeon A, Tracy JA, Pittock SJ, Parisi JE, Klein CJ, Lennon VA. Purkinje cell cytoplasmic autoantibody type 1 accompaniments: the cerebellum and beyond. Arch Neurol. 2011 Oct; 68(10):1282-9. Epub 2011 Jun 13. 2169965
    View PubMed
  31. Somers KJ, Lennon VA, Rundell JR, Pittock SJ, Drubach DA, Trenerry MR, Lachance DH, Klein CJ, Aston PA, McKeon A. Psychiatric manifestations of voltage-gated potassium-channel complex autoimmunity. J Neuropsychiatry Clin Neurosci. 2011 Fall; 23(4):425-33. 2215446
    View PubMed
  32. Costanzi C, Matiello M, Lucchinetti CF, Weinshenker BG, Pittock SJ, Mandrekar J, Thapa P, McKeon A. Azathioprine: tolerability, efficacy, and predictors of benefit in neuromyelitis optica. Neurology. 2011 Aug 16; 77(7):659-66. Epub 2011 Aug 3. 2181968
    View PubMed
  33. Keegan BM, Krecke KN, Pittock SJ. Reply to Duprez et al. and List et al. regarding chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids. Brain. 2011 Aug; 134(Pt 8):e186. Epub 2011 Mar 08. 2151636
    View PubMed
  34. Rudzinski LA, Pittock SJ, McKeon A, Lennon VA, Britton JW. Extratemporal EEG and MRI findings in ANNA-1 (anti-Hu) encephalitis. Epilepsy Res. 2011 Aug; 95(3):255-62. Epub 2011 May 12. 2165307
    View PubMed
  35. Flanagan EP, Lennon VA, Pittock SJ. Autoimmune myelopathies. Continuum. 2011 Aug; 17(4):776-99. 2195347
  36. Magana SM, Keegan BM, Weinshenker BG, Erickson BJ, Pittock SJ, Lennon VA, Rodriguez M, Thomsen K, Weigand S, Mandrekar J, Linbo L, Lucchinetti CF. Beneficial plasma exchange response in central nervous system inflammatory demyelination. Arch Neurol. 2011 Jul; 68(7):870-8. Epub 2011 Mar 14. 2151952
    View PubMed
  37. Flanagan EP, McKeon A, Lennon VA, Kearns J, Weinshenker BG, Krecke KN, Matiello M, Keegan BM, Mokri B, Aksamit AJ, Pittock SJ. Paraneoplastic isolated myelopathy: clinical course and neuroimaging clues. Neurology. 2011 Jun 14; 76(24):2089-95. 2169550
    View PubMed
  38. Cornelius JR, Pittock SJ, McKeon A, Lennon VA, Aston PA, Josephs KA, Tippmann-Peikert M, Silber MH. Sleep manifestations of voltage-gated potassium channel complex autoimmunity. Arch Neurol. 2011 Jun; 68(6):733-8. 2170004
    View PubMed
  39. Pittock SJ, Lennon VA, Dege CL, Talley NJ, Locke GR 3rd. Neural autoantibody evaluation in functional gastrointestinal disorders: a population-based case-control study. Dig Dis Sci. 2011 May; 56(5):1452-9. Epub 2010 Dec 23. 2136055
    View PubMed
  40. Popescu BF, Lennon VA, Parisi JE, Howe CL, Weigand SD, Cabrera-Gomez JA, Newell K, Mandler RN, Pittock SJ, Weinshenker BG, Lucchinetti CF. Neuromyelitis optica unique area postrema lesions: nausea, vomiting, and pathogenic implications. Neurology. 2011 Apr 5; 76(14):1229-37. Epub 2011 Mar 02. 2151540
    View PubMed
  41. Dhamija R, Renaud DL, Pittock SJ, McKeon A, Lachance DH, Nickels KC, Wirrell EC, Kuntz NL, King MD, Lennon VA. Neuronal voltage-gated potassium channel complex autoimmunity in children. Pediatr Neurol. 2011 Apr; 44(4):275-81. 2152018
    View PubMed
  42. McKeon A, Pittock SJ, Lennon VA. CSF complements serum for evaluating paraneoplastic antibodies and NMO-IgG. Neurology. 2011 Mar 22; 76(12):1108-10. 2155627
    View PubMed
  43. McKeon A, Ahlskog JE, Britton JW, Lennon VA, Pittock SJ. "Reversible extralimbic paraneoplastic encephalopathies with large abnormalities on magnetic resonance images": Correction. Arch Neurol. 2011 Mar; 68(3):371. 2162432
  44. McKeon A, Lindell EP, Atkinson JL, Weinshenker BG, Piepgras DG, Pittock SJ. Pearls & oy-sters: clues for spinal dural arteriovenous fistulae. Neurology. 2011 Jan 18; 76(3):e10-2. 2143339
    View PubMed
  45. Rashtak S, Rashtak S, Snyder MR, Pittock SJ, Wu TT, Gandhi MJ, Murray JA. Serology of celiac disease in gluten-sensitive ataxia or neuropathy: role of deamidated gliadin antibody. J Neuroimmunol. 2011 Jan; 230(1-2):130-4. Epub 2010 Nov 06. 2124095
    View PubMed
  46. Popescu BF, Parisi JE, Cabrera-Gomez JA, Newell K, Mandler RN, Pittock SJ, Lennon VA, Weinshenker BG, Lucchinetti CF. Absence of cortical demyelination in neuromyelitis optica. Neurology. 2010 Dec 7; 75(23):2103-9. 2129813
    View PubMed
  47. Apiwattanakul M, Popescu BF, Matiello M, Weinshenker BG, Lucchinetti CF, Lennon VA, McKeon A, Carpenter AF, Miller GM, Pittock SJ. Intractable vomiting as the initial presentation of neuromyelitis optica. Ann Neurol. 2010 Nov; 68(5):757-61. 2121145
    View PubMed
  48. Fischer PR, Sandroni P, Pittock SJ, Porter CB, Lehwald LM, Raj SR. Isolated sympathetic failure with autoimmune autonomic ganglionopathy. Pediatr Neurol. 2010 Oct; 43(4):287-90. 2114829
    View PubMed
  49. Flanagan EP, McKeon A, Lennon VA, Boeve BF, Trenerry MR, Tan KM, Drubach DA, Josephs KA, Britton JW, Mandrekar JN, Lowe V, Parisi JE, Pittock SJ. Autoimmune dementia: clinical course and predictors of immunotherapy response. Mayo Clin Proc. 2010 Oct; 85(10):881-97. 2118657
    View PubMed
  50. Pittock SJ, Parisi JE, McKeon A, Roemer SF, Lucchinetti CF, Tan KM, Keegan BM, Hunter SF, Duncan PR, Baehring JM, Matsumoto JY, Lennon VA. Paraneoplastic jaw dystonia and laryngospasm with antineuronal nuclear autoantibody type 2 (anti-Ri). Arch Neurol. 2010 Sep; 67(9):1109-15. 2114825
    View PubMed
  51. Pittock SJ, Debruyne J, Krecke KN, Giannini C, van den Ameele J, De Herdt V, McKeon A, Fealey RD, Weinshenker BG, Aksamit AJ, Krueger BR, Shuster EA, Keegan BM. Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). Brain. 2010 Sep; 133(9):2626-34. Epub 2010 Jul 17. 2196895
    View PubMed
  52. Mateen FJ, Keegan BM, Krecke K, Parisi JE, Trenerry MR, Pittock SJ. Sporadic leucodystrophy with neuroaxonal spheroids: persistence of DWI changes and neurocognitive profiles: a case study. J Neurol Neurosurg Psychiatry. 2010 Jun; 81(6):619-22. Epub 2010 Feb 22. 1987755
    View PubMed
  53. Chamberlain JL, Pittock SJ, Oprescu AM, Dege C, Apiwattanakul M, Kryzer TJ, Lennon VA. Peripherin-IgG association with neurologic and endocrine autoimmunity. J Autoimmun. 2010 Jun; 34(4):469-77. Epub 2010 Jan 12. 1980515
    View PubMed
  54. Apiwattanakul M, McKeon A, Pittock SJ, Kryzer TJ, Lennon VA. Eliminating false-positive results in serum tests for neuromuscular autoimmunity. Muscle Nerve. 2010 May; 41(5):702-4. 1997837
    View PubMed
  55. McKeon A, Apiwattanakul M, Lachance DH, Lennon VA, Mandrekar JN, Boeve BF, Mullan B, Mokri B, Britton JW, Drubach DA, Pittock SJ. Positron emission tomography-computed tomography in paraneoplastic neurologic disorders: systematic analysis and review. Arch Neurol. 2010 Mar; 67(3):322-9. Epub 2010 Jan 11. 1980495
    View PubMed
  56. Kraichely RE, Farrugia G, Pittock SJ, Castell DO, Lennon VA. Neural autoantibody profile of primary achalasia. Dig Dis Sci. 2010 Feb; 55(2):307-11. Epub 2009 Jun 05. 1946919
    View PubMed
  57. Lachance DH, Lennon VA, Pittock SJ, Tracy JA, Krecke KN, Amrami KK, Poeschla EM, Orenstein R, Scheithauer BW, Sejvar JJ, Holzbauer S, Devries AS, Dyck PJ. An outbreak of neurological autoimmunity with polyradiculoneuropathy in workers exposed to aerosolised porcine neural tissue: a descriptive study. Lancet Neurol. 2010 Jan; 9(1):55-66. Epub 2009 Nov 27. 1974057
    View PubMed
  58. Petzold A, Pittock S, Lennon V, Maggiore C, Weinshenker BG, Plant GT. Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis. J Neurol Neurosurg Psychiatry. 2010 Jan; 81(1):109-11. 1982579
    View PubMed
  59. Lim SY, Mason WP, Young NP, Chen R, Bower JH, McKeon A, Pittock SJ, Lang AE. Polymyoclonus, laryngospasm, and cerebellar ataxia associated with adenocarcinoma and multiple neural cation channel autoantibodies. Arch Neurol. 2009 Oct; 66(10):1285-7. 1970065
    View PubMed
  60. Kale N, Pittock SJ, Lennon VA, Thomsen K, Roemer SF, McKeon A, Lucchinetti CF. Humoral MS Pathology (Pattern II) is not Associated with NMO-IgG Arch Neurol. 2009 Oct; 66(10):1298-9. 1955589
  61. Hinson SR, McKeon A, Fryer JP, Apiwattanakul M, Lennon VA, Pittock SJ. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells. Arch Neurol. 2009 Sep; 66(9):1164-7. 1962131
    View PubMed
  62. McKeon A, Fryer JP, Apiwattanakul M, Lennon VA, Hinson SR, Kryzer TJ, Lucchinetti CF, Weinshenker BG, Wingerchuk DM, Shuster EA, Pittock SJ. Diagnosis of neuromyelitis spectrum disorders: comparative sensitivities and specificities of immunohistochemical and immunoprecipitation assays. Arch Neurol. 2009 Sep; 66(9):1134-8. 1962133
    View PubMed
  63. Jacob A, Matiello M, Weinshenker BG, Wingerchuk DM, Lucchinetti C, Shuster E, Carter J, Keegan BM, Kantarci OH, Pittock SJ. Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients. Arch Neurol. 2009 Sep; 66(9):1128-33. 1962135
    View PubMed
  64. Magana SM, Pittock SJ, Lennon VA, Keegan BM, Weinshenker BG, Lucchinetti CF. Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease. Arch Neurol. 2009 Aug; 66(8):964-6. 1957538
    View PubMed
  65. McKeon A, Lennon VA, Lachance DH, Fealey RD, Pittock SJ. Ganglionic acetylcholine receptor autoantibody: oncological, neurological, and serological accompaniments. Arch Neurol. 2009 Jun; 66(6):735-41. 1946899
    View PubMed
  66. Magana SM, Matiello M, Pittock SJ, McKeon A, Lennon VA, Rabinstein AA, Shuster E, Kantarci OH, Lucchinetti CF, Weinshenker BG. Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders. Neurology. 2009 Feb 24; 72(8):712-7. 1926170
    View PubMed
  67. McKeon A, Ahlskog JE, Britton JW, Lennon VA, Pittock SJ. Reversible extralimbic paraneoplastic encephalopathies with large abnormalities on magnetic resonance images. Arch Neurol. 2009 Feb; 66(2):268-71. 1923956
    View PubMed
  68. McKeon A, Lennon VA, Jacob A, Matiello M, Lucchinetti CF, Kale N, Chan KH, Weinshenker BG, Apiwattinakul M, Wingerchuk DM, Pittock SJ. Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica. Muscle Nerve. 2009 Jan; 39(1):87-90. 1910809
    View PubMed
  69. Jacob A, Matiello M, Weinshenker BG, Wingerchuk DM, Lucchinetti CF, Shuster E, Carter J, Keegan BM, Kantarci OH, Pittock SJ. Treatment of NMO with mycophenolate mofetil: retrospective analysis of 24 patients. Arch Neurol. 2009; Sep;66(9):1128-33. 1944489
  70. Hinson SR, Roemer SF, Lucchinetti CF, Fryer JP, Kryzer TJ, Chamberlain JL, Howe CL, Pittock SJ, Lennon VA. Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2. J Exp Med. 2008 Oct 27; 205(11):2473-81. Epub 2008 Oct 06. 1907245
    View PubMed
  71. Geschwind MD, Tan KM, Lennon VA, Barajas RF Jr, Haman A, Klein CJ, Josephson SA, Pittock SJ. Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease. Arch Neurol. 2008 Oct; 65(10):1341-6. 1909223
    View PubMed
  72. Dhamija R, Tan KM, Pittock SJ, Foxx-Orenstein A, Benarroch E, Lennon VA. Serologic profiles aiding the diagnosis of autoimmune gastrointestinal dysmotility. Clin Gastroenterol Hepatol. 2008 Sep; 6(9):988-92. Epub 2008 Jul 02. 1904579
    View PubMed
  73. McKeon A, Lennon VA, Lotze T, Tenenbaum S, Ness JM, Rensel M, Kuntz NL, Fryer JP, Homburger H, Hunter J, Weinshenker BG, Krecke K, Lucchinetti CF, Pittock SJ. CNS aquaporin-4 autoimmunity in children. Neurology. 2008 Jul 8; 71(2):93-100. Epub 2008 May 28. 1891521
    View PubMed
  74. Lucchinetti CF, Gavrilova RH, Metz I, Parisi JE, Scheithauer BW, Weigand S, Thomsen K, Mandrekar J, Altintas A, Erickson BJ, Konig F, Giannini C, Lassmann H, Linbo L, Pittock SJ, Bruck W. Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain. 2008 Jul; 131(Pt 7):1759-75. Epub 2008 Jun 05. 1904594
    View PubMed
  75. Matiello M, Lennon VA, Jacob A, Pittock SJ, Lucchinetti CF, Wingerchuk DM, Weinshenker BG. NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology. 2008 Jun 3; 70(23):2197-200. Epub 2008 Apr 23. 1883284
    View PubMed
  76. Tan KM, Lennon VA, Klein CJ, Boeve BF, Pittock SJ. Clinical spectrum of voltage-gated potassium channel autoimmunity. Neurology. 2008 May 13; 70(20):1883-90. 1883192
    View PubMed
  77. Pittock SJ, Lennon VA. Aquaporin-4 autoantibodies in a paraneoplastic context. Arch Neurol. 2008 May; 65(5):629-32. 1888424
    View PubMed
  78. Keegan BM, Pittock SJ, Lennon VA. Autoimmune myelopathy associated with collapsin response-mediator protein-5 immunoglobulin G. Ann Neurol. 2008 Apr; 63(4):531-4. 1883072
    View PubMed
  79. Pittock SJ. Neuromyelitis optica: a new perspective. Semin Neurol. 2008 Feb; 28(1):95-104. 1872189
    View PubMed
  80. Banwell B, Tenembaum S, Lennon VA, Ursell E, Kennedy J, Bar-Or A, Weinshenker BG, Lucchinetti CF, Pittock SJ. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders. Neurology. 2008 Jan 29; 70(5):344-52. Epub 2007 Dec 19. 1898636
    View PubMed
  81. Pittock SJ, Lennon VA, de Seze J, Vermersch P, Homburger HA, Wingerchuk DM, Lucchinetti CF, Zephir H, Moder K, Weinshenker BG. Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol. 2008 Jan; 65(1):78-83. 1861304
    View PubMed
  82. Pittock SJ, Rodriguez M. Benign multiple sclerosis: a distinct clinical entity with therapeutic implications. Curr Top Microbiol Immunol. 2008; 318:1-17. 1867502
    View PubMed
  83. Kraichely RE, Gianrico F, Pittock SJ, Castell DO, Lennon VA. Neural autoantibody profile of primary achalasia. Dig Dis Sci. 2008; (in press). 1944482
  84. Banwell BL, Tenembaum S, Lennon VA, Ursell E, Kennedy J, Bar-Or A, Weinshenker BG, Lucchinetti C, Pittock SJ. Neuromyelitis Optica-IgG in Childhood Inflammatory Demyelinating CNS Disorders. Neurology. 2007 Dec 19. 1851337
  85. Hinson SR, Pittock SJ, Lucchinetti CF, Roemer SF, Fryer JP, Kryzer TJ, Lennon VA. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology. 2007 Dec 11; 69(24):2221-31. Epub 2007 Oct 10. 1858462
    View PubMed
  86. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock S, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurology. 2007 Sep; 6(9):805-15. 1841540
    View PubMed
  87. McKeon A, Pittock SJ, Glass GA, Josephs KA, Bower JH, Lennon VA, Ahlskog JE. Whole-body tremulousness: isolated generalized polymyoclonus. Arch Neurol. 2007 Sep; 64(9):1318-22. 1841349
    View PubMed
  88. McKeon A, Ozelius LJ, Hardiman O, Greenway MJ, Pittock SJ. Heterogeneity of presentation and outcome in the Irish rapid-onset dystonia-parkinsonism kindred. Mov Disord. 2007 Jul 15; 22(9):1325-7. 1837037
    View PubMed
  89. Jacob A, Matiello M, Wingerchuk DM, Lucchinetti CF, Pittock SJ, Weinshenker BG. Neuromyelitis optica: changing concepts. J Neuroimmunol. 2007 Jul; 187(1-2):126-38. Epub 2007 May 21. 1837068
    View PubMed
  90. Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain. 2007 May; 130(Pt 5):1194-205. 1820483
    View PubMed
  91. Pittock SJ, Lucchinetti CF. The pathology of MS: new insights and potential clinical applications. Neurologist. 2007 Mar; 13(2):45-56. 1820508
    View PubMed
  92. Wingerchuk DM, Pittock SJ, Lucchinetti CF, Lennon VA, Weinshenker BG. A secondary progressive clinical course is uncommon in neuromyelitis optica. Neurology. 2007 Feb 20; 68(8):603-5. 1810384
    View PubMed
  93. Pittock SJ, Reindl M, Achenbach S, Berger T, Bruck W, Konig F, Morales Y, Lassmann H, Bryant S, Moore SB, Keegan BM, Lucchinetti CF. Myelin oligodendrocyte glycoprotein antibodies in pathologically proven multiple sclerosis: frequency, stability and clinicopathologic correlations. Mult Scler. 2007 Jan; 13(1):7-16. 1812367
    View PubMed
  94. Gavrilova Ralitza H, Weigand Stephen D, Thomsen Kristine M, Parisi Joseph E, Scheithauer Bernd, Giannini Caterina, Pittock SJ. Clinical and Radiographic Spectrum of Pathologically Confirmed Tumefactive Multiple Sclerosis. Brain. 2007. 1871394
  95. Scott TF, Kassab SL, Pittock SJ. Neuromyelitis optica IgG status in acute partial transverse myelitis. Arch Neurol. 2006 Oct; 63(10):1398-400. 1787107
    View PubMed
  96. Pittock SJ, Yoshikawa H, Ahlskog JE, Tisch SH, Benarroch EE, Kryzer TJ, Lennon VA. Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction. Mayo Clin Proc. 2006 Sep; 81(9):1207-14. 1779645
    View PubMed
  97. Pittock SJ, Lucchinetti CF. Inflammatory transverse myelitis: evolving concepts. Curr Opin Neurol. 2006 Aug; 19(4):362-8. 1777856
    View PubMed
  98. Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol. 2006 Jul; 63(7):964-8. 1772829
    View PubMed
  99. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006 May 23; 66(10):1485-9. 1762931
    View PubMed
  100. Weinshenker BG, Wingerchuk DM, Vukusic S, Linbo L, Pittock SJ, Lucchinetti CF, Lennon VA. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol. 2006 Mar; 59(3):566-9. 1754245
    View PubMed
  101. Pittock SJ, Lennon VA, Krecke K, Wingerchuk DM, Lucchinetti CF, Weinshenker BG. Brain abnormalities in neuromyelitis optica. Arch Neurol. 2006 Mar; 63(3):390-6. 1754343
    View PubMed
  102. Castillo P, Woodruff B, Caselli R, Vernino S, Lucchinetti C, Swanson J, Noseworthy J, Aksamit A, Carter J, Sirven J, Hunder G, Fatourechi V, Mokri B, Drubach D, Pittock S, Lennon V, Boeve B. Steroid-responsive encephalopathy associated with autoimmune thyroiditis. Arch Neurol. 2006 Feb; 63(2):197-202. 1748479
    View PubMed
  103. Pittock SJ, Lennon VA, deSeze, J, Vermersch P, Homburger HH, Wingerchuk DM, Lucchinetti CF, Zephir H, Moder K, Weinshenker BG. Neuromyelitis optica spectrum disorders and non-organ-specific autoimmunity. Annals of Neurology. 2006. 1824751
  104. Weinshenker BG, Wingerchuk DM, Pittock SJ, Lucchinetti CF, Lennon VA. NMO-IgG: a specific biomarker for neuromyelitis optica. Dis Markers. 2006; 22(4):197-206. 1802107
    View PubMed
  105. Weinshenker B, Wingerchuk D, Pittock S, Lucchinetti C, Lennon V. A Secondary Progressive Clinical Course is Uncommon in Neuromyelitis Optica. Neurology. 2006. 1784127
    View PubMed
  106. Lin F, Murphy R, White B, Kelly J, Feighery C, Doyle R, Pittock S, Moroney J, Smith O, Livingstone W, Keenan C, Jackson J. Circulating levels of beta2-glycoprotein I in thrombotic disorders and in inflammation. Lupus. 2006; 15(2):87-93. 1759859
    View PubMed
  107. Pittock SJ, Rodriguez M. Disability in multiple sclerosis. Is MS a more benign condition than previously supposed? Cuadernos de Esclerosis Multiple. 2006. 1732797
  108. Pittock SJ, McClelland RL, Achenbach SJ, Konig F, Bitsch A, Bruck W, Lassmann H, Parisi JE, Scheithauer BW, Rodriguez M, Weinshenker BG, Lucchinetti CF. Clinical course, pathological correlations, and outcome of biopsy proved inflammatory demyelinating disease. J Neurol Neurosurg Psychiatry. 2005 Dec; 76(12):1693-7. 1736562
    View PubMed
  109. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005 Aug 15; 202(4):473-7. Epub 2005 Aug 08. 1731901
    View PubMed
  110. Pittock SJ, Lucchinetti CF, Parisi JE, Benarroch EE, Mokri B, Stephan CL, Kim KK, Killmann MW, Lennon VA. Amphiphysin autoimmunity: paraneoplastic accompaniments. Ann Neurol. 2005 Jul; 58(1):96-107. 1721484
    View PubMed
  111. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004 Dec 11-17; 364(9451):2106-12. 1674431
    View PubMed
  112. Pittock SJ, McClelland RL, Mayr WT, Rodriguez M, Matsumoto JY. Prevalence of tremor in multiple sclerosis and associated disability in the Olmsted County population. Mov Disord. 2004 Dec; 19(12):1482-5. 1677685
    View PubMed
  113. Pittock SJ, Kryzer TJ, Lennon VA. Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome. Annals of Neurology. 2004 Nov; 56(5):715-9. 1673937
    View PubMed
  114. Pittock SJ, Weinshenker BG, Wijdicks EFM. Mechanical ventilation and tracheostomy in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2004 Sep; 75(9):1331-3. 1662248
    View PubMed
  115. Meldrum D, Pittock SJ, Hardiman O, Ni Dhuill C, O'Regan M. Recovery of the upper limb post ischaemic stroke and the predictive value of the Orpington Prognostic Score. Clin Rehabil. 2004 Sep; 18(6):694-702. 1732790
    View PubMed
  116. Pittock SJ, McClelland RL, Mayr WT, Jorgensen NW, Weinshenker BG, Noseworthy J, Rodriguez M. Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study. Ann Neurol 2004 Aug; 56(2):303-6. 1657403
    View PubMed
  117. Pittock SJ, Parrett T, Adler CH, Parisi JE, Dickson DW, Ahlskog JE. Neuropathology of primary restless leg syndrome: absence of specific tau- and alpha-synuclein pathology. Mov Disord. 2004 Jun; 19(6):695-9. 1652842
    View PubMed
  118. Pittock SJ, Mayr WT, McClelland RL, Jorgensen NW, Weigand SD, Noseworthy JH, Rodriguez M. Quality of life is favorable for most patients with multiple sclerosis-a population-based cohort study. Arch Neurol. 2004 May; 61(5):679-86. 1645449
    View PubMed
  119. Kantarci OH, Hebrink DD, Achenbach SJ, Pittock SJ, Altintas A, Schaefer-Klein JL, Atkinson EJ, de Andrade M, McMurray CT, Rodriguez M, Weinshenker BG. Association of APOE polymorphisms with disease severity in MS is limited to women. Neurology. 2004 Mar 9; 62(5):811-4. 1639186
    View PubMed
  120. Pittock SJ, Mayr WT, McClelland RL, Jorgensen NW, Weigand SD, Noseworthy JH, Rodriguez M. Disability profile of MS did not change over 10 years in a population-based prevalence cohort. Neurology. 2004 Feb 24; 62(4):601-6. 1639040
    View PubMed
  121. Pittock SJ, Mayr WT, McClelland RL, Jorgensen NW, Weigand SD, Noseworthy JH, Weinshenker BG, Rodriguez M. Change in MS-related disability in a population-based cohort - A 10-year follow-up study. Neurology. 2004 Jan 13; 62(1):51-9. 1517874
    View PubMed
  122. Balding J, Livingstone WJ, Pittock SJ, et al. The IL-6 G-174C polymorphism may be associated with ischaemic stroke in patients without a history of hypertension. IJMS. 2004; 173(4):200-3. 1732792
    View PubMed
  123. Mayr WT, Pittock SJ, McClelland RL, Jorgensen NW, Noseworthy JH, Rodriguez M. Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985-2000. Neurology. 2003 Nov 25; 61(10):1373-7. 1429007
    View PubMed
  124. Rabinstein AA, Pittock SJ, Miller GM, Schindler JJ, Wijdicks EFM. Pseudosubarachnoid haemorrhage in subdural haematoma. J Neurol Neurosurg Psychiatry. 2003 Aug; 74(8):1131-2. 1405082
    View PubMed
  125. Pittock SJ, Meldrum D, Ni Dhuill C, Hardiman O, Moroney JT. The Orpington Prognostic Scale within the first 48 hours of admission as a predictor of outcome in ischemic stroke. J Stroke Cerebrovasc Dis. 2003 Jul-Aug; 12(4):175-81. 1732785
    View PubMed
  126. Pittock SJ, Meldrum D, Hardiman O, Deane C, Dunne P, Hussey A, Gorman M, Moroney JT. Patient and hospital delays in acute ischaemic stroke in a Dublin teaching hospital. Ir Med J. 2003 Jun; 96(6):167-8 170-1. 1732786
    View PubMed
  127. Pittock SJ, Lucchinetti CF, Lennon VA. Anti-neuronal nuclear autoantibody type 2: Paraneoplastic accompaniments. Ann Neurol 2003 May; 53(5):580-7. 1341210
    View PubMed
  128. Pittock SJ, Rabinstein AA, Edwards BS, Wijdicks EFM. OKT3 neurotoxicity presenting as akinetic mutism. Transplantation. 2003 Apr 15; 75(7):1058-60. 1340405
    View PubMed
  129. Pittock SJ, Meldrum D, Hardiman O, Thornton J, Brennan P, Moroney JT. The Oxfordshire Community Stroke Project classification: correlation with imaging, associated complications, and prediction of outcome in acute ischemic stroke. J Stroke Cerebrovasc Dis. 2003 Jan; 12(1):1-7. 1732788
    View PubMed
  130. Pittock SJ, Moore AP, Hardiman O, Ehler E, Kovac M, Bojakowski J, Al Khawaja I, Brozman M, Kanovsky P, Skorometz A, Slawek J, Reichel G, Stenner A, Timerbaeva S, Stelmasiak Z, Zifko UA, Bhakta B, Coxon E. A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after stroke. Cerebrovasc Dis. 2003; 15(4):289-300. 1732787
    View PubMed
  131. Pittock SJ, Meldrum D, Hardiman O. The "spray can" sign: validation of a clinical observation in chronic inflammatory demyelinating polyneuropathy. Arch Neurol. 2002 Oct; 59(10):1637-40. 1732784
    View PubMed
  132. Pittock SJ. Unilateral osteoarthritis--"the working hand". N Engl J Med. 2002 Mar 7; 346(10):e3. 1732783
    View PubMed
  133. Pittock SJ, Payne TA, Harper CM. Reversible myelopathy in a 34-year-old man with vitamin B-12 deficiency. Mayo Clin Proc. 2002 Mar; 77(3):291-4. 1008336
    View PubMed
  134. Pittock SJ, Rodriguez M, Wijdicks EF. Rapid weaning from mechanical ventilator in acute cervical cord multiple sclerosis lesion after steroids. Anesth Analg. 2001 Dec; 93(6):1550-1, table of contents. 1006906
    View PubMed
  135. Bakheit AM, Pittock S, Moore AP, Wurker M, Otto S, Erbguth F, Coxon L. A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke. Eur J Neurol. 2001 Nov; 8(6):559-65. 1732779
    View PubMed
  136. Henderson RD, Pittock SJ, Piepgras DG, Wijdicks EF. Acute spontaneous spinal epidural hematoma. Arch Neurol. 2001 Jul; 58(7):1145-6. 1005567
    View PubMed
  137. Pittock SJ, Hardiman O, Goode B, Moroney JT. Evaluation of stroke management in an Irish university teaching hospital: the Royal College of Physicians stroke audit package. Ir J Med Sci. 2001 Jul-Sep; 170(3):163-8. 1732780
    View PubMed
  138. Pittock SJ, Moroney JT, Alexander M, Brennan P, Moorhouse D. Traumatic bilateral carotid dissection with concomitant cerebral infarction. J Emerg Med. 2001 Jan; 20(1):33-8. 1979975
    View PubMed
  139. Pittock SJ, Joyce C, O’Keane V, Hugle B, Hardiman MO, Brett F, Green AJ, Barton DE, King MD, Webb DW. Rapid onset dystonia-parkinsonism: a clinical and genetic analysis of a new kindred. Neurology. 2000 Oct 10; 55(7):991-5. 1732778
    View PubMed
  140. Ni Dhuill CM, Fox GB, Pittock SJ, O’Connell AW, Murphy KJ, Regan CM. Polysialylated neural cell adhesion molecule expression in the dentate gyrus of the human hippocampal formation from infancy to old age. J Neurosci Res. 1999 Jan 1; 55(1):99-106. 1732777
    View PubMed